Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1975 3
1978 2
1979 1
1980 1
1982 1
1983 2
1984 2
1985 1
1986 2
1987 2
1988 1
1989 2
1990 2
1992 1
1993 5
1994 3
1995 5
1996 4
1997 7
1998 5
1999 5
2000 6
2001 9
2002 4
2003 6
2004 1
2005 3
2006 6
2007 2
2008 1
2009 4
2010 4
2011 4
2012 4
2013 8
2014 5
2015 6
2016 5
2017 5
2018 5
2019 4
2020 7
2021 9
2022 4
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Nasopharyngeal Non-Hodgkin Lymphoma"
Page 1
Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Wong Y, et al. J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46. doi: 10.1007/s00432-021-03824-y. Epub 2021 Oct 27. J Cancer Res Clin Oncol. 2022. PMID: 34705104 Free PMC article. Review.
This review will present an overview on the spectrum of cancers linked to EBV based on observations of associations and proportions in the published literature while also using these observations to estimate the incidence and mortality burden of some of these cancer …
This review will present an overview on the spectrum of cancers linked to EBV based on observations of associations and proportions i …
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y, Gao S, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X, Wu R. Xue Y, et al. Expert Opin Drug Deliv. 2021 Feb;18(2):187-203. doi: 10.1080/17425247.2021.1825376. Epub 2020 Oct 5. Expert Opin Drug Deliv. 2021. PMID: 32954856 Review.
ABBREVIATIONS: Treg: regulatory T cell; MDSC: myeloid-derived suppressor cell; TAM: tumor-associated macrophage; IL: interleukin; PD-1: programmed cell death protein-1; PD-L1: programmed death-ligand-1; NSCLC: non-small cell lung cancer; SCLC: small cell lung cancer; HNSCC …
ABBREVIATIONS: Treg: regulatory T cell; MDSC: myeloid-derived suppressor cell; TAM: tumor-associated macrophage; IL: interleukin; PD-1: prog …
Association of HLA diversity with the risk of 25 cancers in the UK Biobank.
Wang QL, Wang TM, Deng CM, Zhang WL, He YQ, Xue WQ, Liao Y, Yang DW, Zheng MQ, Jia WH. Wang QL, et al. EBioMedicine. 2023 Jun;92:104588. doi: 10.1016/j.ebiom.2023.104588. Epub 2023 May 4. EBioMedicine. 2023. PMID: 37148584 Free PMC article.
Besides, a lower risk of non-Hodgkin lymphoma was associated with an increased diversity of HLA class I (OR(hetero) = 0.92, 95% CI = 0.87-0.98, P = 8.38 10(-3)) and class II locus (OR(hetero) = 0.89, 95% CI = 0.86-0.92, P = 1.65 10(-10)). A lower risk of H …
Besides, a lower risk of non-Hodgkin lymphoma was associated with an increased diversity of HLA class I (OR(hetero) = 0 …
The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.
Zhang Z, Liu E, Zhang D, Zhao W, Wang G, Zhang Y, Huo Y, Zhang C, Li W. Zhang Z, et al. Diagn Pathol. 2023 Nov 30;18(1):129. doi: 10.1186/s13000-023-01413-w. Diagn Pathol. 2023. PMID: 38037110 Free PMC article.
Concurrently, we assembled a control group, including 20 cases afflicted with nasopharyngeal mucosal lymphoid hyperplasia diseases during the same timeframe. ...No statistically significant differences were observed in the distribution of PLK1 and p-PLK1 expression …
Concurrently, we assembled a control group, including 20 cases afflicted with nasopharyngeal mucosal lymphoid hyperplasia diseases du …
Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB, Bougmiza I, Bouabid Z, Achour B, Regaieg H, Sriha B, Belkadhi M, Omri HE, Khelif A. Youssef YB, et al. Kulak Burun Bogaz Ihtis Derg. 2012 Sep-Oct;22(5):275-83. doi: 10.5606/kbbihtisas.2012.053. Kulak Burun Bogaz Ihtis Derg. 2012. PMID: 22991988 Free article. Review.
Most patients presented with nasal obstruction (69%) and rhinism (52%). The site of extranodal NK/T-cell lymphoma primarily involved nasal cavity in 39%. Orbital extension was observed in 26%. ...CONCLUSION: Nasal type NK/T-cell lymphoma showed a poor respons …
Most patients presented with nasal obstruction (69%) and rhinism (52%). The site of extranodal NK/T-cell lymphoma primarily involved …
Unilateral sinonasal symptoms.
Habesoglu TE, Habesoglu M, Surmeli M, Uresin T, Egeli E. Habesoglu TE, et al. J Craniofac Surg. 2010 Nov;21(6):2019-22. doi: 10.1097/SCS.0b013e3181f5389a. J Craniofac Surg. 2010. PMID: 21119491
OBJECTIVE: The aim of the study was to describe the pathology in patients with unilateral sinonasal symptoms and to identify variables that may predict neoplastic pathology. STUDY DESIGN: Retrospective chart review. ...There were 12 cases of antrochoanal polyp, 14 of nasal …
OBJECTIVE: The aim of the study was to describe the pathology in patients with unilateral sinonasal symptoms and to identify variables that …
Comparison of Primary B/NKT Non-Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses.
Peng J, Qiu J, Cheng D, Rao Y, Mao M, Qiu K, Li J, Chen F, Liu F, Liu J, Mu X, Yu W, Zhang W, Xu W, Zhao Y, Ren J. Peng J, et al. Otolaryngol Head Neck Surg. 2023 May;168(5):1107-1118. doi: 10.1002/ohn.194. Epub 2023 Feb 8. Otolaryngol Head Neck Surg. 2023. PMID: 36939485
OBJECTIVE: We aimed to compare clinical and survival differences between B-cell (B-NHL) and NKT-cell non-Hodgkin lymphomas (NKT-NHL) located in the nasal cavity (NC), nasopharynx, and paranasal sinuses, which are always categorized as one sinonasal type. ...C …
OBJECTIVE: We aimed to compare clinical and survival differences between B-cell (B-NHL) and NKT-cell non-Hodgkin lymphomas (NK …
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.
Argirion I, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Middeldorp JM, Sarathkumara YD, Hsu WL, Chien YC, Lou PJ, Wang CP, Rothman N, Lan Q, Chen CJ, Mbulaiteye SM, Jarrett RF, Glimelius I, Smedby KE, Hjalgrim H, Hildesheim A, Doolan DL, Liu Z. Argirion I, et al. Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):687-696. doi: 10.1158/1055-9965.EPI-22-0452. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36788424 Free PMC article.
BACKGROUND: Epstein-Barr virus (EBV) is linked to multiple cancers, including classical Hodgkin lymphoma (cHL), endemic Burkitt lymphoma (eBL), nasopharyngeal carcinoma (NPC), and extranodal natural killer/T-cell lymphoma (NKTCL). ...EBNA3A, BBL …
BACKGROUND: Epstein-Barr virus (EBV) is linked to multiple cancers, including classical Hodgkin lymphoma (cHL), endemic Burkit …
Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging.
Zhang Y, Deng Y, Zou Q, Jing B, Cai P, Tian X, Yang Y, Li B, Liu F, Li Z, Liu Z, Feng S, Peng T, Dong Y, Wang X, Ruan G, He Y, Cui C, Li J, Luo X, Huang H, Chen H, Li S, Sun Y, Xie C, Wang L, Li C, Cai Q. Zhang Y, et al. Cell Rep Med. 2024 May 21;5(5):101551. doi: 10.1016/j.xcrm.2024.101551. Epub 2024 May 1. Cell Rep Med. 2024. PMID: 38697104 Free PMC article.
Accurate diagnosis and prognosis prediction are conducive to early intervention and improvement of medical care for natural killer/T cell lymphoma (NKTCL). Artificial intelligence (AI)-based systems are developed based on nasopharynx magnetic resonance imagin …
Accurate diagnosis and prognosis prediction are conducive to early intervention and improvement of medical care for natural killer/T …
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Faizan M, Anwar S, Khan S. Faizan M, et al. J Coll Physicians Surg Pak. 2018 Jan;28(1):48-51. doi: 10.29271/jcpsp.2018.01.48. J Coll Physicians Surg Pak. 2018. PMID: 29290192
OBJECTIVE: To describe the patient demographics and outcome analysis in paediatric non-Hodgkin lymphoma (NHL) patients. STUDY DESIGN: An observational study. ...Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43.8%), B cell …
OBJECTIVE: To describe the patient demographics and outcome analysis in paediatric non-Hodgkin lymphoma (NHL) patients. …
168 results